HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pui Y Lee Selected Research

Pui Y Lee Research Topics

Disease

15Inflammation (Inflammations)
05/2024 - 01/2009
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 12/2005
6Macrophage Activation Syndrome
11/2023 - 01/2020
6Arthritis (Polyarthritis)
11/2023 - 01/2019
5Vasculitis (Vasculitides)
01/2023 - 01/2017
5Tertiary Lymphoid Structures
04/2013 - 04/2006
4Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2023 - 01/2019
3Eosinophilia
10/2023 - 11/2022
3Peritonitis
12/2019 - 11/2009
3Hemorrhage
01/2019 - 10/2011
3Proteinuria
06/2013 - 11/2007
3Glomerulonephritis
04/2012 - 11/2007
3Nephritis
01/2009 - 11/2007
2Simian Acquired Immunodeficiency Syndrome
11/2023 - 01/2023
2Lung Diseases (Lung Disease)
10/2023 - 01/2022
2Pure Red-Cell Aplasia
01/2023 - 01/2020
2Cytokine Release Syndrome
01/2023 - 01/2020
2deficiency of adenosine deaminase 2
01/2023 - 01/2022
2Infections
01/2022 - 01/2018
2Stroke (Strokes)
01/2022 - 01/2021
2Lupus Nephritis
10/2020 - 01/2009
2Autoimmune Diseases (Autoimmune Disease)
07/2015 - 12/2005
1Nasal Polyps (Nasal Polyp)
05/2024
1Exanthema (Rash)
10/2023
1Anaphylaxis (Anaphylactic Shock)
10/2023
1Down Syndrome (Down's Syndrome)
10/2023
1Drug Hypersensitivity (Drug Allergy)
10/2023
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
08/2023
1Aneurysm (Aneurysms)
08/2023
1Neoplasms (Cancer)
01/2023
1Juvenile gout
01/2022
1Cytopenia
11/2020
1Lymphopenia (Lymphocytopenia)
11/2020
1Hyperferritinemia
11/2020
1Thrombocytopenia (Thrombopenia)
11/2020
1Dermatomyositis (Dermatopolymyositis)
01/2020
1Pulmonary Alveolar Proteinosis
01/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020
1Osteoporosis
01/2019
1Rheumatoid Arthritis
01/2019
1Compression Fractures (Compression Fracture)
01/2019
1Insulin Resistance
09/2017
1Obesity
09/2017
1Tuberous Sclerosis (Bourneville's Disease)
05/2017

Drug/Important Bio-Agent (IBA)

13AutoantibodiesIBA
01/2022 - 12/2005
11pristane (pristan)IBA
10/2020 - 12/2008
10Interferon Type IIBA
11/2023 - 12/2005
9CytokinesIBA
05/2024 - 08/2011
5Interleukin-1 (Interleukin 1)IBA
11/2023 - 11/2009
5Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2010
4AntigensIBA
11/2023 - 09/2008
4Adenosine DeaminaseIBA
01/2023 - 01/2020
4Antigen-Antibody Complex (Immune Complex)IBA
07/2015 - 11/2007
3Interleukin-6 (Interleukin 6)IBA
05/2024 - 11/2009
3Janus Kinase InhibitorsIBA
01/2023 - 01/2019
2CollagenIBA
11/2023 - 05/2015
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
11/2023 - 01/2021
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2023 - 10/2011
2Mechanistic Target of Rapamycin Complex 1IBA
11/2022 - 05/2017
2Immunoglobulin E (IgE)IBA
11/2022 - 11/2009
2Tumor Necrosis Factor InhibitorsIBA
01/2022 - 01/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 11/2009
2tofacitinibIBA
01/2020 - 01/2019
2EnzymesIBA
01/2020 - 05/2015
2LigandsIBA
06/2013 - 12/2005
2RibonucleoproteinsIBA
12/2008 - 12/2005
2DNA (Deoxyribonucleic Acid)IBA
12/2008 - 12/2005
1dupilumabIBA
05/2024
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2024
1Interleukin-6 InhibitorsIBA
10/2023
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2023
1Methotrexate (Mexate)FDA LinkGeneric
10/2023
1Interleukin-17 (Interleukin 17)IBA
08/2023
1Interferon-gamma (Interferon, gamma)IBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1FebuxostatFDA Link
01/2022
1Neutralizing AntibodiesIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1ProteomeIBA
01/2022
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2020
1fibrin fragment D (D-dimer)IBA
11/2020
1Interleukin-10 (Interleukin 10)IBA
11/2020
1Interleukin-18 (Interleukin 18)IBA
01/2020
1InterferonsIBA
01/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1IntegrinsIBA
12/2019
1Phosphotransferases (Kinase)IBA
01/2019
1GlucocorticoidsIBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Interleukin-33IBA
09/2017
1osteoblast cadherinIBA
09/2017
1Complement Receptors (Complement Receptor)IBA
01/2017
1Complement System Proteins (Complement)IBA
01/2017

Therapy/Procedure

6Therapeutics
10/2023 - 10/2011
2Intraperitoneal Injections
01/2017 - 10/2011
1Biological Therapy
10/2023
1Aftercare (After-Treatment)
01/2020
1Ligation
12/2019
1Glycemic Control
09/2017